CEP43 and myeloproliferative disorder: For instance two CpG sites were within genes, TNS3 and FGFR1OP, that can interact with and potentially influence the function of the fibroblast growth factor receptor (FGFR), and which has previously been observed in cases of developmental disorder and myeloproliferative disorder, respectively [44, 45].